{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:41:49Z","timestamp":1791283309203,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.yjmcc.2012.02.002","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T02:55:51Z","timestamp":1329188151000},"page":"998-1008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG"],"prefix":"10.1016","volume":"52","author":[{"given":"Malin K.B.","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Mirams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Duker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sartipy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun P.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon A.B.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2012.02.002_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.scr.2009.11.004","article-title":"Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Braam","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/scd.2007.0280","article-title":"In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes","volume":"18","author":"Caspi","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000080317.92718.99","article-title":"Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization","volume":"93","author":"He","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.scr.2010.02.001","article-title":"Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Jonsson","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1258\/ebm.2010.009345","article-title":"Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype","volume":"235","author":"Pekkanen-Mattila","year":"2010","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","article-title":"The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes","volume":"61","author":"Peng","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.scr.2010.01.002","article-title":"Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs","volume":"4","author":"Otsuji","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1634\/stemcells.2006-0466","article-title":"Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: A Molecular and Electrophysiological Approach","volume":"25","author":"Sartiani","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1113\/jphysiol.2004.068213","article-title":"Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes","volume":"559","author":"Satin","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9149(96)00450-X","article-title":"From first class to third class: recent upheaval in antiarrhythmic therapy\u2013lessons from clinical trials","volume":"78","author":"Lazzara","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bjp.0703770","article-title":"Differences in action potential and early afterdepolarization properties in LQT2 and LQT3 models of long QT syndrome","volume":"132","author":"Studenik","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0070","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.hrthm.2004.10.032","article-title":"Use of preclinical assays to predict risk of drug-induced torsades de pointes","volume":"2","author":"Belardinelli","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1634\/stemcells.2007-1033","article-title":"Molecular Signature of Cardiomyocyte Clusters Derived from Human Embryonic Stem Cells","volume":"26","author":"Synnergren","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2010.10.093","article-title":"Inhibition of lysosomal degradation rescues pentamidine-mediated decreases of KIR2.1 ion channel expression but not that of Kv11.1","volume":"652","author":"Nalos","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0090","doi-asserted-by":"crossref","first-page":"H1038","DOI":"10.1152\/ajpheart.00679.2005","article-title":"Isolation and characterization of IKr in cardiac myocytes by Cs+ permeation","volume":"290","author":"Zhang","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1529\/biophysj.104.043299","article-title":"A Computational Model of the Human Left-Ventricular Epicardial Myocyte","volume":"87","author":"Iyer","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0100","doi-asserted-by":"crossref","first-page":"H397","DOI":"10.1152\/ajpheart.2000.279.1.H397","article-title":"Mathematical models of action potentials in the periphery and center of the rabbit sinoatrial node","volume":"279","author":"Zhang","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pbiomolbio.2007.07.011","article-title":"Contributions of HERG K+ current to repolarization of the human ventricular action potential","volume":"96","author":"Fink","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0110","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/bioinformatics\/btn390","article-title":"The CellML Model Repository","volume":"24","author":"Lloyd","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0115","first-page":"1885","article-title":"Cellular Open Resource (COR): current status and future directions","volume":"367","author":"Garny","year":"2009","journal-title":"Philos Transact A Math Phys Eng Sci"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0120","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000145162.64183.C8","article-title":"Increased Short-Term Variability of Repolarization Predicts d-Sotalol-Induced Torsades de Pointes in Dogs","volume":"110","author":"Thomsen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00395-003-0424-9","article-title":"A hyperpolarization activated inward current (If) is present in infant ventricular myocytes","volume":"98","author":"Zorn-Pauly","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0130","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/eurheartj\/ehm339","article-title":"Pacemaker current (If) in the human sinoatrial node","volume":"28","author":"Verkerk","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yjmcc.2009.05.004","article-title":"Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype","volume":"48","author":"de Boer","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/europace\/eum121","article-title":"Effects of heart failure on brain-type Na+ channels in rabbit ventricular myocytes","volume":"9","author":"Verkerk","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0145","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.98.23.2545","article-title":"Novel, Ultraslow Inactivating Sodium Current in Human Ventricular Cardiomyocytes","volume":"98","author":"Maltsev","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0008-6363(03)00366-3","article-title":"Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents","volume":"59","author":"Schram","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.76.3.351","article-title":"Characteristics of the Delayed Rectifier Current (IKr and IKs) in Canine Ventricular Epicardial, Midmyocardial, and Endocardial Myocytes : A Weaker IKs Contributes to the Longer Action Potential of the M Cell","volume":"76","author":"Liu","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0160","series-title":"Cardiac Cellular Electrophysiology","author":"Carmeliet","year":"2002"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005344-200408000-00008","article-title":"Antagonism by Ranolazine of the Pro-Arrhythmic Effects of Increasing Late INa in Guinea Pig Ventricular Myocytes","volume":"44","author":"Song","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCULATIONAHA.105.550111","article-title":"Restricting Excessive Cardiac Action Potential and QT Prolongation: A Vital Role for IKs in Human Ventricular Muscle","volume":"112","author":"Jost","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0175","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/01.CIR.0000068344.54010.B3","article-title":"Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for beta-Adrenergic Receptor Stimulation","volume":"107","author":"Volders","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0180","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1161\/01.CIR.88.5.2389","article-title":"Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors","volume":"88","author":"Goethals","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vascn.2010.02.007","article-title":"Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37\u00b0C: Cisapride versus dofetilide","volume":"61","author":"Milnes","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0190","first-page":"303","article-title":"Inhibition of L-type Ca(2+) current in Guinea pig ventricular myocytes by cisapride","volume":"11","author":"Chiang","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2009.00338.x","article-title":"Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential","volume":"159","author":"Abi-Gerges","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2011.01558.x","article-title":"Comparison of I(Kr) blocking drugs Moxifloxacin and Dofetilide\/E-4031 in 5 screening models of pro-arrhythmia reveals insufficient specificity of isolated cardiomyocytes","volume":"165","author":"Nalos","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0005-2736(87)90124-6","article-title":"A mechanistic interpretation of the action of toxin II from Anemonia sulcata on the cardiac sodium channel","volume":"901","author":"Schreibmayer","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0210","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High Purity Human Induced Pluripotent Stem Cell (hiPSC) Derived Cardiomyocytes: Electrophysiological Properties of Action Potentials and Ionic Currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0215","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-2828(03)00078-6","article-title":"Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects","volume":"35","author":"Herfst","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0220","first-page":"H1301","article-title":"Sodium current in isolated human ventricular myocytes","volume":"265","author":"Sakakibara","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0225","doi-asserted-by":"crossref","first-page":"H1596","DOI":"10.1152\/ajpheart.00948.2009","article-title":"Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure","volume":"301","author":"Mishra","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0230","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1006\/jmcc.1994.1149","article-title":"L-type Calcium Currents of Human Myocytes from Ventricle of Non-failing and Failing Hearts and from Atrium","volume":"26","author":"Mewes","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00395-009-0082-7","article-title":"Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations","volume":"105","author":"B\u00e1r\u00e1ndi","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/01.RES.62.3.563","article-title":"A model for early afterdepolarizations: induction with the Ca2+ channel agonist Bay K8644","volume":"62","author":"January","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0008-6363(98)00021-2","article-title":"Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes","volume":"38","author":"Bosch","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yjmcc.2009.08.033","article-title":"IKs restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation","volume":"48","author":"Johnson","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0255","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/01.CIR.98.21.2314","article-title":"Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT Syndrome : Effects of \u00df-Adrenergic Agonists and Antagonists and Sodium Channel Blockers on Transmural Dispersion of Repolarization and Torsade de Pointes","volume":"98","author":"Shimizu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0260","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1472-8206.2010.00920.x","article-title":"I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?","volume":"25","author":"Puddu","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0265","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/eurheartj\/ehr073","article-title":"Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation","volume":"32","author":"Matsa","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09855","article-title":"Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome","volume":"471","author":"Yazawa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1469-7580.2002.00031.x","article-title":"Cardiomyocyte differentiation of mouse and human embryonic stem cells","volume":"200","author":"Mummery","year":"2002","journal-title":"J Anat"},{"key":"10.1016\/j.yjmcc.2012.02.002_bb0280","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282812000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282812000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:23:04Z","timestamp":1758313384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282812000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0022282812000843"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2012.02.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2012.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}